The activity of 29 antimicrobial agents was tested against 95 strains of Campylobacter fetus subsp. jejuni isolated from human stools. Furazolidone and gentamycin were the most active agents. The tetracyclines, erythromycin, and chloramphenicol were very active against most of the strains, but with each antibiotic a few resistant strains were found. The penicillins were relatively inactive, and the cephalosporins tested were only active against occasional strains.
The aims of this study were to determine the general susceptibility pattern of Campylobacter fetus subsp.jejuni; to recognize those antimicrobial agents to which it is generally susceptible and which might therefore be useful in the treatment of enteritis or septicemia due to Campylobacter; and to identify those antimicrobial agents to which it is always resistant and which might be used to develop an improved selective medium.
In an early study of susceptibilities, Butzler et al. (4) showed that most strains of Campylobacter (Vibrio) fetus were resistant to the penicillins and almost all to cephalothin. We have now determined the in vitro activity of 29 antimicrobial agents against 95 strains isolated from patients' stools.
MATERIALS AND METHODS
Bacterial strains. Ninety-five strains of C. fetus subsp. jejuni were used in this study. They were isolated from human stools in the laboratory of the Sint Pierre Hospital in 1976 and 1977 by means of the selective coproculture technique described by Butzler et al. (3) , simplified by omitting the preliminary filtration of the stools (10 ,ug/ml did not inhibit any of them. Penicillin G
The distribution of the minimal inhibitory showed little activity; the majority of the strains concentrations (MICs) of the different antibi-were only inhibited by concentrations of 6.25 or otics against the 95 C. fetus subsp. jejuni strains 12.5 pug/ml. The cephalosporins were inactive is listed in Tables 1, 2, and 3. against all but a few strains. There was no dif- The tetracyclines were generally very effective, but we found five strains that were totally resistant to them. Minocycline was the most active tetracycline and inhibited the majority of strains at a concentration of 0.097 ,ug/ml or less. Chloramphenicol inhibited the majority of strains at concentrations of 1.56 or 3.12 .tg/ml.
Thiamphenicol showed less activity than chloramphenicol.
Polymyxin B and colistin were in general inactive against our strains of C. fetus subsp. jejuni.
Clindamycin at a concentration of 0.78 ,ug/ml inhibited all but 12 of the 95 campylobacters tested (87%). Lincomycin at a level of 6.25 ,g/ml did not inhibit any of them.
Among the aminoglycosides, gentamicin was the most active. All but one of our strains were very susceptible to it. The MIC of gentamicin for the exceptional strain was 12.5 ,ug/ml.
The MICs of erythromycin needed for most strains were very low. However, for eight strains (8.4%) MICs were at least 12.5 ,ug/ml, and these strains were considered resistant.
Rifampin and vancomycin showed no activity against any strain.
Furazolidone was very active, and 95% of the strains were inhibited by a concentration of 0.78 ,4g/ml.
The levels of nalidixic acid needed showed peaks at 3.12 to 6.25 ,ug/ml. The range of MICs of metronidazole was very broad, and 20 strains were inhibited only by 12.5,ug/ml.
Trimethoprim was not active against our strains of C. fetus subsp. jejuni, and the distribution of the MICs was characterized by a peak covering the values from 100 to 200 ,ug/ml.
Sulfamethoxazole and the 20:1 combination of sulfamethoxazole and trimethoprim were only moderately active. Almost 40% of the strains were resistant to both.
DISCUSSION
In 1957, King (9) described a small group of vibrios which were similar to, but not the same as, C. (Vibrio) fetus and which she suspected of being causative agents of enteritis in infants and young children. They could be distinguished from C. fetus by their biochemical and antigenic properties. They were provisionally called "related vibrios." Wron and Chatelain (16) considered they were represented by the two species Campylobacter jejuni and Campylobacter coli. Smibert (14) , however, listed them as C. fetus subsp. jejuni.
The pathogenic role of this organism in human disease has only recently been recognized. Indeed, up to 1972 only 12 cases of C. jejuni infection were known-7 infants, 2 children, and 3 adults (7, 9, 11, 17, 18) . The three adults were all debilitated and died; only one infant had any preexisting pathology. In all these cases of enteritis, blood cultures yielded campylobacters, but the authors did not succeed in isolating the agent from the stools. There are a number of reasons why disease due to C. jejuni remained unrecognized in man for such a long time. Blood cultures are an uncommon diagnostic procedure in enteritis. There is a natural reluctance to do blood cultures in infants and children unless clearly indicated. It is not yet clear how often blood cultures are positive in Campylobacter enteritis. In 1973, Butzler et al. (3) in Brussels developed a successful selective coproculture technique and isolated C. fetus subsp. jejuni from the feces of 5.1% of children with diarrhea and 1.3% of children without diarrhea. Further, specific complement-fixing antibodies to the strain of C. fetus subsp. jejuni isolated from the stools were demonstrated in children with diarrhea (1). Similar findings have recently been reported by Skirrow, who found that most of the patients with campylobacters in their stools had a distinctive clinical illness with severe abdominal pain (13) .
C. jejuni enteritis occurs at all ages, but especially in infants under 2 years of age, and the diarrhea may take different forms. In some patients it is acute, purulent, and blood-stained and is then often accompanied by fever. In others, diarrhea may be accompanied by nausea and vomiting, leading to dehydration and disturbance of the electrolyte balance. A chronic diarrhea may also occur, with offensive and blood-stained stools.
The site of infection seems to be the ileum and jejunum (13) . Cadranel et al. (6) isolated C. jejuni from ileal, jejunal, and gastric aspirates in affected children. C. jejuni has been isolated both from the feces and from the blood of patients with hemorrhagic enteritis and fever (5, 8) . Experimentally, infection of the bowel wall has been demonstrated in chicks given human isolates by mouth (2) .
The epidemiology of C. jejuni infections is not yet understood.
In 1974, Butzler (Thesis, Free University of Brussels, Belgium) described five outbreaks of diarrhea in creches due to C. jejuni and considered that the organism spread from person to person. King considered animal reservoirs (poultry, pigs, sheep, and others) as a likely source of campylobacteriosis in humans (9) .
It seems that C. fetus subsp. jejuni is one of the commonest of the bacteria recognized as VOL. 14, 1978 In conclusion, we have found in vitro that furazolidone and gentamicin showed excellent activity and that the tetracyclines and erythromycin, except against a few resistant strains, were also very active. On the other hand, penicillin G and the cephalosporins were inactive, and all the strains were resistant to cloxacillin, vancomycin, and rifampin.
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